Wetherby Asset Management Inc Biogen Inc. Transaction History

Wetherby Asset Management Inc

$2.13 Billion
Q3 2024

A detailed history of Wetherby Asset Management Inc transactions in Biogen Inc. stock. As of the latest transaction made, Wetherby Asset Management Inc holds 3,045 shares of BIIB stock, worth $458,698. This represents 0.03% of its overall portfolio holdings.

Number of Shares

3,045

Previous 4,559 33.21%

Holding current value

$458,698

Previous $1.06 Million 44.13%

% of portfolio

0.03%

Previous 0.05%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$189.07 - $236.8 $286,251 - $358,515	-1,514 Reduced 33.21%	3,045 $590,000
Q2 2024 Aug 14, 2024	BUY	$190.52 - $236.72 $399,139 - $495,928	2,095 Added 85.02%	4,559 $1.06 Million
Q1 2024 May 15, 2024	SELL	$212.02 - $267.71 $9,328 - $11,779	-44 Reduced 1.75%	2,464 $531,000
Q4 2023 Feb 14, 2024	SELL	$222.59 - $267.94 $39,398 - $47,425	-177 Reduced 6.59%	2,508 $648,000
Q3 2023 Nov 14, 2023	BUY	$253.3 - $285.89 $12,918 - $14,580	51 Added 1.94%	2,685 $690,000
Q2 2023 Aug 14, 2023	BUY	$275.25 - $318.06 $43,489 - $50,253	158 Added 6.38%	2,634 $750,000
Q1 2023 May 12, 2023	SELL	$256.56 - $292.34 $71,067 - $80,978	-277 Reduced 10.06%	2,476 $688,000
Q4 2022 Feb 14, 2023	BUY	$252.44 - $306.72 $168,377 - $204,582	667 Added 31.98%	2,753 $762,000
Q3 2022 Nov 14, 2022	SELL	$194.69 - $268.46 $39,327 - $54,228	-202 Reduced 8.83%	2,086 $557,000
Q2 2022 Aug 15, 2022	SELL	$187.54 - $223.02 $105,585 - $125,560	-563 Reduced 19.75%	2,288 $467,000
Q1 2022 May 16, 2022	SELL	$193.77 - $244.14 $18,795 - $23,681	-97 Reduced 3.29%	2,851 $600,000
Q4 2021 Feb 14, 2022	SELL	$223.92 - $287.77 $354,017 - $454,964	-1,581 Reduced 34.91%	2,948 $707,000
Q3 2021 Nov 15, 2021	BUY	$282.99 - $369.05 $17,828 - $23,250	63 Added 1.41%	4,529 $1.28 Million
Q2 2021 Aug 16, 2021	SELL	$259.0 - $414.71 $30,044 - $48,106	-116 Reduced 2.53%	4,466 $1.55 Million
Q1 2021 May 14, 2021	BUY	$242.95 - $284.63 $54,177 - $63,472	223 Added 5.12%	4,582 $1.28 Million
Q4 2020 Feb 11, 2021	BUY	$236.26 - $355.63 $984,022 - $1.48 Million	4,165 Added 2146.91%	4,359 $1.07 Million
Q3 2020 Dec 16, 2020	SELL	$264.77 - $305.71 $957,143 - $1.11 Million	-3,615 Reduced 94.91%	194 $55,000
Q3 2020 Dec 16, 2020	SELL	$264.77 - $305.71 $60,367 - $69,701	-228 Reduced 5.65%	3,809 $1.08 Million
Q3 2020 Nov 13, 2020	SELL	$264.77 - $305.71 $108,820 - $125,646	-411 Reduced 9.24%	4,037 $1.15 Million
Q2 2020 Aug 14, 2020	BUY	$258.66 - $342.55 $81,477 - $107,903	315 Added 7.62%	4,448 $1.19 Million
Q1 2020 May 06, 2020	BUY	$268.85 - $341.04 $117,218 - $148,693	436 Added 11.79%	4,133 $1.31 Million
Q4 2019 Jan 28, 2020	SELL	$220.06 - $304.07 $19,145 - $26,454	-87 Reduced 2.3%	3,697 $1.1 Million
Q3 2019 Oct 31, 2019	BUY	$217.44 - $243.88 $95,238 - $106,819	438 Added 13.09%	3,784 $881,000
Q2 2019 Jul 25, 2019	SELL	$219.29 - $241.72 $207,009 - $228,183	-944 Reduced 22.0%	3,346 $782,000
Q1 2019 May 09, 2019	BUY	$216.71 - $338.96 $38,140 - $59,656	176 Added 4.28%	4,290 $1.01 Million
Q4 2018 Jan 30, 2019	SELL	$278.5 - $352.75 $5,848 - $7,407	-21 Reduced 0.51%	4,114 $1.24 Million
Q3 2018 Nov 07, 2018	BUY	$293.51 - $383.83 $103,315 - $135,108	352 Added 9.3%	4,135 $1.46 Million
Q2 2018 Jul 24, 2018	BUY	$257.52 - $306.91 $91,419 - $108,953	355 Added 10.36%	3,783 $1.1 Million
Q1 2018 May 04, 2018	SELL	$260.13 - $367.91 $34,337 - $48,564	-132 Reduced 3.71%	3,428 $939,000
Q4 2017 Feb 09, 2018	BUY	$307.64 - $344.58 $78,140 - $87,523	254 Added 7.68%	3,560 $1.14 Million
Q3 2017 Nov 13, 2017	BUY	$281.15 - $329.69 $929,481 - $1.09 Million	3,306	3,306 $1.04 Million

Others Institutions Holding BIIB

# of Institutions

1,038

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.7B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wetherby Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wetherby Asset Management Inc with notifications on news.

Account

Wetherby Asset Management Inc Biogen Inc. Transaction History